XEPLION 50 mg, suspension for injection with extended release syringe
Active ingredients: PALIPÉRIDONE, Paliperidone palmitate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Suspension for injection with extended releasesyringeintramusculaire
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- XEPLION 50 mg, suspension injectable à libération prolongée
- Pharmaceutical form
- suspension injectable à libération prolongée
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue(s) préremplie(s) polycyclooléfine avec 2 aiguille(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- Schizophrénie chez l'adulte stabilisé par un traitement oral ; JOURNAL OFFICIEL ; 11/01/13
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Jan 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65554816CIP74176664CIP133400941766640Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PALIPÉRIDONEsuspension | 50 mg · une seringue préremplie | FT |
| PALMITATE DE PALIPÉRIDONEsuspension | 78 mg · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.